Dailypharm Live Search Close

Daiichi Sankyo Korea appoints Jeongtae Kim as new CEO

By Eo, Yun-Ho | translator Kim, Jung-Ju

23.02.20 16:31:49

°¡³ª´Ù¶ó 0
CEO Dae-Jung Kim resigns at the end of March

Serve as company advisor

 ¡ãKim Jeong-tae, new president

Daiichi Sankyo Korea appointed Vice President Kim Jung-tae (49) as the new CEO. Daiichi Sankyo announced on the 20th that it will appoint Vice President Kim Jeong-tae as the new CEO and President Kim Dae-jung will retire on March 31. Accordingly, from April 1st, President Kim Dae-jung will support the company as an advisor, and new President Kim Jung-tae will be inaugurated as the representative. President Kim Jeong-tae graduated from the College of Pharmacy at Sungkyunkwan University, obtained an MBA from Korea University, and has accumulated extensive experience and expertise by holding various positions at Daiichi Sankyo Korea and Daiichi Sankyo Headquarters.

He started his career in 2008 at Daiichi

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)